Related Experiment Video
Updated: Jun 28, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
[Recent advances in the detection of human erythropoietin and human growth hormone doping]
Lei Guo1, Zhaoyang Zhang, Jijun Tang
1Beijing Institute of Toxicology and Pharmacology, Beijing 100850, China. guoleibmi@gmail.com
Abstract:
In the World Anti-doping Agency 2008 Prohibited List, the prohibited substances of S2 item are hormones and related substances, which are belonging to the endogenous biomacromolecules. How to identify the substances derived from endogenous secretion or exogenous administration is the main problem in doping control analysis and attracts more attention. The present report summarizes the main analytical strategies, including indirect blood tests and direct detection approaches developed to identify the presence of erythropoietin (EPO) and human growth hormone (hGH), which have wide pharmaceutical applications and thus been fully examined. The recent physico-chemical or immunoanalytical methodologies on the discrimination of recombinant and endogenous proteins are emphasized.
